You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...

In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...

HICOR’s Value in Cancer Care Initiative (VCCI) engages oncology providers, patient partners, payers, health system representatives and researchers to improve the value of cancer care delivery in ...

Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred Hutch Cancer Center and Seattle Children’s Research Institute.

An international team of researchers co-led by Fred Hutchinson Cancer Center’s genetic epidemiologist Ulrike (Riki) Peters, PhD, has pinpointed what’s likely driving many colorectal cancers in people ...

Zinc’s immune-boosting properties are well-established, but we’re still untangling how it works. In a new study published in late March in the scientific journal Blood, Fred Hutchinson Cancer Research ...

Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...

If there is one thing most of us have learned about the coronavirus itself, we know it is covered with spikes. In news broadcasts about the COVID-19 crisis, that gray Styrofoam ball dotted with red ...

They are genes commonly associated with breast cancer in women, but in fact men who carry certain mutations in their BRCA1 or BRCA2 genes are at higher risk of developing certain types of cancer ...